Benjamin F. Edwards & Company’s Kite Pharma, Inc. KITE Stock Holding History

Benjamin F. Edwards & Company’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-100	Closed	-$10K	–	1615
2017 Q2	$10K	Buy	+100	New	+$8.16K	﹤0.01%	1104
2016 Q3	–	Sell	-200	Closed	-$10K	–	1179
2016 Q2	$10K	Sell	200 -107	-35%	-$5.26K	﹤0.01%	808
2016 Q1	$14K	Hold	307	–	–	﹤0.01%	747
2015 Q4	$19K	Hold	307	–	–	﹤0.01%	712
2015 Q3	$17K	Hold	307	–	–	﹤0.01%	763
2015 Q2	$19K	Buy	307 +200	+187%	+$11.4K	﹤0.01%	798
2015 Q1	$6K	Buy	+107	New	+$7.17K	﹤0.01%	985

Other funds holding KITE

Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

WCM

Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCSAM

Tyrus Capital S.A.M. Monaco $10.5M AUM 4.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Benjamin F. Edwards & Company's KITE Position: Q3 2017 in Review

Benjamin F. Edwards & Company sold out of Kite Pharma, Inc. (KITE) in Q3 2017, closing a stake of 100 shares — an estimated $10K sold.

Benjamin F. Edwards & Company first reported a position in KITE in Q1 2015 and held it in 7 quarters. The position peaked at $19K in Q4 2015. 244 funds tracked by Wall St. Rank hold KITE as of Q3 2017.

Benjamin F. Edwards & Company reported no remaining Kite Pharma, Inc. position as of Q3 2017 after selling out during the quarter.
Benjamin F. Edwards & Company sold 100 Kite Pharma, Inc. shares in Q3 2017, an estimated $10K.
Benjamin F. Edwards & Company first reported a position in Kite Pharma, Inc. in Q1 2015 and held it in 7 quarters.
Benjamin F. Edwards & Company's Kite Pharma, Inc. position peaked at $19K in Q4 2015.
244 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q3 2017.

Based on Benjamin F. Edwards & Company's 13F filing for Q3 2017, filed 24 Oct 2017.